-
A649713-25mgAndrogen receptor antagonist 1 is an orally available full androgen receptor ( AR ) antagonist with an IC 50 of 59 nM Androgen receptor antagonist 1 (Compound 6) can be used in the synthesis of PROTAC AR degraders, which results 24% and 47 % AR
-
A649713-50mgAndrogen receptor antagonist 1 is an orally available full androgen receptor ( AR ) antagonist with an IC 50 of 59 nM Androgen receptor antagonist 1 (Compound 6) can be used in the synthesis of PROTAC AR degraders, which results 24% and 47 % AR
-
A649713-5mgAndrogen receptor antagonist 1 is an orally available full androgen receptor ( AR ) antagonist with an IC 50 of 59 nM Androgen receptor antagonist 1 (Compound 6) can be used in the synthesis of PROTAC AR degraders, which results 24% and 47 % AR
-
A655963-1mlAndrogen receptor antagonist 1 is an orally available full androgen receptor ( AR ) antagonist with an IC 50 of 59 nM Androgen receptor antagonist 1 (Compound 6) can be used in the synthesis of PROTAC AR degraders, which results 24% and 47 % AR
-
A286773-5mgPotent and selective androgen receptor degrader.
-
A651640-10mgARD-2128 is a highly potent, orally bioavailable PROTAC androgen receptor (AR) degrader. ARD-2128 effectively reduces AR protein, suppresses AR-regulated genes in tumor tissues, and inhibits growth of tumor without signs of toxicity. ARD-2128 has
-
A651640-1mgARD-2128 is a highly potent, orally bioavailable PROTAC androgen receptor (AR) degrader. ARD-2128 effectively reduces AR protein, suppresses AR-regulated genes in tumor tissues, and inhibits growth of tumor without signs of toxicity. ARD-2128 has
-
A651640-5mgARD-2128 is a highly potent, orally bioavailable PROTAC androgen receptor (AR) degrader. ARD-2128 effectively reduces AR protein, suppresses AR-regulated genes in tumor tissues, and inhibits growth of tumor without signs of toxicity. ARD-2128 has
-
-
-
-